A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2006
10/17/2006	CA2294744C Multiple unit effervescent dosage form
10/17/2006	CA2293808C Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
10/17/2006	CA2244774C Dihydropyridine derivatives, their preparation and their use as adenosine receptor antagonists
10/17/2006	CA2125662C Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
10/15/2006	CA2504382A1 Composition for improving blood fluidity
10/12/2006	WO2006107708A1 Treatment of disease caused by excess free hemoglobin
10/12/2006	WO2006107093A1 Fibrinolytic agent, method of producing the same and method of using cucurbitaceous fruit
10/12/2006	WO2006107059A1 Medicine for renal perfusion disorder
10/12/2006	WO2006107014A1 Blood purifier
10/12/2006	WO2006106963A1 Triamine derivative
10/12/2006	WO2006106959A1 Anti-cd-20 monoclonal antibody
10/12/2006	WO2006106804A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring
10/12/2006	WO2006074075A3 Adipose-derived stem cells for tissue regeneration and wound healing
10/12/2006	US20060229363 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
10/12/2006	US20060229335 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006	US20060229290 Staurosporine derivatives for hypereosinophilic syndrome
10/12/2006	US20060229236 Cyclic tetrapeptide compound and use thereof
10/12/2006	US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders
10/12/2006	US20060228341 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/12/2006	CA2648522A1 Substituted azetidinones
10/12/2006	CA2602228A1 Triamine derivative
10/12/2006	CA2602025A1 Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring
10/11/2006	EP1709965A2 Methods of treating cytokine mediate diseases
10/11/2006	EP1709963A2 Use of amtolmetin guacyl for the production of a drug for counteracting blood platelet aggregation
10/11/2006	EP1709017A1 Urea derivatives
10/11/2006	EP1536688A4 Mammalian megakaryocyte progenitor cell
10/11/2006	EP1529041B1 Novel prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridil-n-2-hydroxycarbonylethyl)-amide, production and use thereof as medicaments
10/11/2006	EP1140149B1 Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment
10/11/2006	EP1107959B1 Quinazoline derivatives as medicaments
10/11/2006	EP1107807B1 Use of citrate in a catheter lock solution
10/11/2006	EP0944619B1 Novel integrin receptor antagonists
10/11/2006	CN1845917A 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicam
10/11/2006	CN1844160A Sulfonated changium root polysaccharides and preparing method and use thereof
10/11/2006	CN1844118A Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor
10/11/2006	CN1843448A Formulation for kidney and its novel preparation method
10/11/2006	CN1843407A Compound drop pills with Chinese medicinal effective part and its preparation method
10/11/2006	CN1843365A Use of polyene phosphatidylcholine in preparing medicine for treating fat thrombus
10/11/2006	CN1843351A Bilobalide B powder injection and its preparing method
10/11/2006	CN1843210A Giant salamander cooking method
10/11/2006	CN1279044C Non-steroidal progesterone receptor modulators
10/11/2006	CN1279041C Diazabicyclo alkane derivatives with NK1 antagonistic activity
10/11/2006	CN1278737C Compound medicinal formulation with bioactivity
10/11/2006	CN1278680C Medicinal composition for treating bleeding disease and its use
10/10/2006	US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
10/10/2006	US7119186 Nucleotide sequences coding polypeptide for use in the treatment of spinocerebellar ataxia
10/10/2006	US7119170 Administering a polypeptide; blood disorders
10/10/2006	US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis
10/10/2006	US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal
10/10/2006	US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
10/10/2006	US7118888 Gene expression vaccine
10/10/2006	US7118748 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
10/10/2006	CA2356391C Transdermal drug delivery system
10/10/2006	CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
10/05/2006	WO2006105511A1 Monitoring and modulating hgf/hgfr activity
10/05/2006	WO2006105217A2 Spirocyclic thrombin receptor antagonists
10/05/2006	WO2006104400A1 Copper antagonist compositions
10/05/2006	WO2006104398A1 Copper antagonist compositions
10/05/2006	WO2006104396A1 Pre-complexed copper antagonist compositions
10/05/2006	WO2006104280A1 Prophylactic/therapeutic agent for diabetes
10/05/2006	WO2006104086A1 Therapeutic agent for thrombosis
10/05/2006	WO2006104008A1 Urea derivative, medicinal composition containing the same, and medicinal use of these
10/05/2006	WO2006103555A1 4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
10/05/2006	WO2006103545A1 4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors
10/05/2006	WO2006103544A2 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
10/05/2006	WO2006078621A3 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
10/05/2006	US20060223881 Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
10/05/2006	US20060223865 Therapeutic combination
10/05/2006	US20060223819 Quinoline Derivatives as NK-3 Antagonists
10/05/2006	US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics
10/05/2006	US20060223180 Methods to mobilize progenitor/stem cells
10/05/2006	US20060222638 Cholesterol biosynthesis pathway modulators and uses thereof
10/05/2006	CA2603041A1 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
10/05/2006	CA2602538A1 4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
10/05/2006	CA2602351A1 Urea derivative, medicinal composition containing the same, and medicinal use of these
10/05/2006	CA2602227A1 4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors
10/05/2006	CA2601575A1 Spirocyclic thrombin receptor antagonists
10/04/2006	EP1707566A1 Deazapurines and uses thereof
10/04/2006	EP1706396A1 N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
10/04/2006	EP1706120A1 New derivatives of 6- 4 4 - 1 h - indole-2-sulphonyl)-pipera zin-1-carbonyl-phenyl pyradizin-3-one
10/04/2006	EP1706079A2 Antibodies against factor viii with modified glycosylation in the variable region
10/04/2006	EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide
10/04/2006	EP0906091B1 Amidinohydrazones as protease inhibitors
10/04/2006	CN1842590A Method of differentiation from embryo-stem cell of primate to hematogenous cell
10/04/2006	CN1842344A Use of human fibrinogen a alpha or b beta chain peptide for treating shock
10/04/2006	CN1842341A Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng
10/04/2006	CN1841066A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
10/04/2006	CN1840187A Method for preparing highly-active thrombin inhibitor
10/04/2006	CN1840184A Lysozyme liposome and preparation method thereof
10/04/2006	CN1840176A Sublingual tablet of natural hirudin
10/04/2006	CN1840170A Chinese proprietary medicine for treating cerebral thrombosis
10/04/2006	CN1840067A Chewing tablet of asparagus and preparation process thereof
10/04/2006	CN1840040A Chinese medicine for treating aplastic anemia and preparation method thereof
10/04/2006	CN1840030A Effervescence granule of beautyberry and preparation method thereof
10/04/2006	CN1840006A Medicine for treating aplastic anemia
10/04/2006	CN1839957A Method for extracting haw leaf general flavone material for injection using polyamide column
10/04/2006	CN1839954A Capsule for improving immunity and its preparing process
10/04/2006	CN1839953A Medicine for treating idiopathy thrombocytopenia peliosis
10/04/2006	CN1839937A Red sage root and safflower freeze dried and preparation method thereof

1 ... 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 ... 671